曾庆源  熊珍英 （武汉市第三医院, 武汉430060）

摘　要 目的：了解医疗保险用抗菌药物的用药频度及联合用药,指导临床合理用药。方法：利用Foxpro6.0数据库系统,统计2003年医疗保险住院用药品种、金额和联用。采用WHO推荐的限定日剂量(Defined Daily Dose :DDDs) 方法分析药物的临床使用情况。结果：抗菌药物中,头孢类、喹诺酮类、林可霉素类和青霉素类最为常用,占用药总金额的89.33 % 。新型头孢菌素和喹诺酮类药物开始进入临床用药的主导地位。结论：我院住院患者的抗菌药物应用率较高, 但抗菌药物的消费趋势正朝着安全、有效、合理、经济的方向发展。

关键词 医保药品  抗菌药物  DDDs

Analysis of the Use of Antibacterial Agents of Inpatients with Medical Insurance

Zeng Qingyuan, Xiong Zhenying (Wuhan Third Hospital, Wuhan, 430060)

ABSTRACT Objective: Through investigating the frequency and combined usage of antibacterial agents of assigned drugs of medical insurance, the aim was to give guidance for clinical rational drug using. Method: Foxpro6.0 database system was utilized to calculate category, cost and combined usage of drugs in the year of 2003. Defined Daily Dose (DDD) recommended by WHO was adopted to analyze the drug use condition in the clinic. Result: In the antibacterial agents, cephalosporin, quinolone, lincomycin and penicillin were used most frequently and the cost of them accounted for 89.33 % of all antibacterial agents cost. At the same time new cephalosporin and quinolones were in the leading place in the clinical drug use. Conclusion: The rate of application of antibacterial agents in inpatients in our hospital is high. However, the consuming trend of antibacterial drug is becoming safe, effective, reasonable and economical.

KEY WORDS Assigned Drugs of Medical Insurance; Antibacterial agents; DDDs